Robert W. Baird Maintains Hold Rating for Molina Healthcare with $212.85 Price Target

Robert W. Baird analyst Michael Ha maintains a Hold rating for Molina Healthcare, with a price target of $212.85, representing a 32.03% upside from current levels. The analyst consensus is also Hold, with a price target of $212.85. Molina Healthcare's market cap is $8.53B and has a P/E ratio of 7.95.

In a recent update, Robert W. Baird analyst Michael Ha has maintained a Hold rating for Molina Healthcare (MOH) with a price target of $212.85, representing a 32.03% upside from the current price. This recommendation aligns with the analyst consensus, which also stands at Hold with a price target of $212.85. As of the current date, Molina Healthcare's market cap is $8.53 billion, and its P/E ratio is 7.95 [1].

Molina Healthcare, a leading health insurance company, has been under scrutiny for its recent financial performance. The company has been facing challenges in its membership growth and has seen a decline in its stock price. Despite these challenges, analysts at Robert W. Baird believe that the company's fundamentals are sound, and they expect a recovery in its stock price in the coming months.

The Hold rating from Robert W. Baird indicates that the analyst believes that the stock is neither a buy nor a sell at the current price. Instead, they suggest that investors should wait for the company to demonstrate significant improvement in its financial performance before considering a purchase.

Investors should closely monitor Molina Healthcare's earnings reports and other financial indicators to assess the accuracy of the analyst's prediction. The company's ability to improve its membership growth and reduce its operating costs will be crucial in determining its future stock performance.

References:
[1] https://www.marketbeat.com/ratings/by-issuer/robert-w-baird-stock-recommendations/